NeoGenomics's Earnings Outlook
Portfolio Pulse from Benzinga Insights
NeoGenomics (NASDAQ:NEO) is scheduled to release its quarterly earnings report on February 20, 2024, with an expected EPS of $-0.02. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historically, NeoGenomics has shown the ability to beat EPS estimates, leading to significant stock price movements. The company's shares have seen a 9.2% increase over the last 52 weeks, trading at $7.61 as of February 15.
February 19, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
NeoGenomics is expected to report an EPS of $-0.02 for the upcoming quarter. Historical performance shows significant stock price movements post-earnings announcements, with a 9.2% increase in shares over the last 52 weeks.
Given NeoGenomics's history of surpassing EPS estimates and the subsequent positive stock price reactions, there is a strong likelihood of a positive short-term impact on NEO's stock price if the company beats the EPS estimate again and provides optimistic future guidance. The 9.2% increase in share price over the last year further supports investor confidence in the company's performance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100